Imatinib mesylate induced immune thrombocytopenia.

Suppr

超能文献

作者信息

Rajappa Senthil, Varadpande Lalit, Paul Tara Roshni, Digumarti Raghunadharao

出版信息

Leuk Lymphoma. 2007 Nov;48(11):2261-3. doi: 10.1080/10428190701615934.

DOI:10.1080/10428190701615934

PMID:17926182

Abstract

摘要

相似文献

Imatinib mesylate induced immune thrombocytopenia.

Leuk Lymphoma. 2007 Nov;48(11):2261-3. doi: 10.1080/10428190701615934.

Imatinib mesylate: a new pill for chronic myelogenous leukemia.

Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.

Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.

Ann Oncol. 2004 Feb;15(2):358-9. doi: 10.1093/annonc/mdh068.

Imatinib mesylate.

Am J Health Syst Pharm. 2001 Dec 1;58(23):2241-2. doi: 10.1093/ajhp/58.23.2241.

Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.

Br J Haematol. 2003 Mar;120(6):1091-2. doi: 10.1046/j.1365-2141.2003.04208_3.x.

Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.

Leuk Lymphoma. 2006 Jul;47(7):1427-30. doi: 10.1080/10428190600593877.

Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.

Leuk Lymphoma. 2007 Jan;48(1):195-6. doi: 10.1080/10428190600923157.

Precipitation of porphyria cutanea tarda by imatinib mesylate?

Br J Haematol. 2003 Apr;121(2):375. doi: 10.1046/j.1365-2141.2003.04277.x.

Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.

Indian J Dermatol Venereol Leprol. 2006 Jan-Feb;72(1):63-4. doi: 10.4103/0378-6323.19727.

[Imatinib mesylate-induced acute cytolytic hepatitis].

Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):918-9. doi: 10.1016/s0399-8320(04)95160-3.

引用本文的文献

Current awareness: pharmacoepidemiology and drug safety.

Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):i-xvi. doi: 10.1002/pds.1487.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Imatinib mesylate induced immune thrombocytopenia.

Leuk Lymphoma. 2007 Nov;48(11):2261-3. doi: 10.1080/10428190701615934.

Imatinib mesylate: a new pill for chronic myelogenous leukemia.

Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.

Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.

Ann Oncol. 2004 Feb;15(2):358-9. doi: 10.1093/annonc/mdh068.

Imatinib mesylate.

Am J Health Syst Pharm. 2001 Dec 1;58(23):2241-2. doi: 10.1093/ajhp/58.23.2241.

Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.

Br J Haematol. 2003 Mar;120(6):1091-2. doi: 10.1046/j.1365-2141.2003.04208_3.x.

Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.

Leuk Lymphoma. 2006 Jul;47(7):1427-30. doi: 10.1080/10428190600593877.

Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.

Leuk Lymphoma. 2007 Jan;48(1):195-6. doi: 10.1080/10428190600923157.

Precipitation of porphyria cutanea tarda by imatinib mesylate?

Br J Haematol. 2003 Apr;121(2):375. doi: 10.1046/j.1365-2141.2003.04277.x.

Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.

Indian J Dermatol Venereol Leprol. 2006 Jan-Feb;72(1):63-4. doi: 10.4103/0378-6323.19727.

[Imatinib mesylate-induced acute cytolytic hepatitis].

Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):918-9. doi: 10.1016/s0399-8320(04)95160-3.

引用本文的文献

Current awareness: pharmacoepidemiology and drug safety.

Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):i-xvi. doi: 10.1002/pds.1487.